ID   GBM7
AC   CVCL_DG63
SY   GBM 7
DR   cancercelllines; CVCL_DG63
DR   GEO; GSM1026857
DR   Progenetix; CVCL_DG63
DR   Wikidata; Q54835478
RX   PubMed=19147502;
RX   PubMed=23468990;
CC   Group: Cancer stem cell line.
CC   Omics: Array-based CGH.
CC   Omics: DNA methylation analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
RX   PubMed=19147502; DOI=10.1074/jbc.M807111200;
RA   Griffero F., Daga A., Marubbi D., Capra M.C., Melotti A.,
RA   Pattarozzi A., Gatti M., Bajetto A., Porcile C., Barbieri F.,
RA   Favoni R.E., Lo Casto M., Zona G., Spaziante R., Florio T., Corte G.;
RT   "Different response of human glioma tumor-initiating cells to
RT   epidermal growth factor receptor kinase inhibitors.";
RL   J. Biol. Chem. 284:7138-7148(2009).
//
RX   PubMed=23468990; DOI=10.1371/journal.pone.0057462;
RA   Baronchelli S., Bentivegna A., Redaelli S., Riva G., Butta V.,
RA   Paoletta L., Isimbaldi G., Miozzo M., Tabano S., Daga A., Marubbi D.,
RA   Cattaneo M., Biunno I., Dalpra L.;
RT   "Delineating the cytogenomic and epigenomic landscapes of glioma stem
RT   cell lines.";
RL   PLoS ONE 8:E57462-E57462(2013).
//